380 related articles for article (PubMed ID: 35228752)
1. Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1.
McCulloch JA; Davar D; Rodrigues RR; Badger JH; Fang JR; Cole AM; Balaji AK; Vetizou M; Prescott SM; Fernandes MR; Costa RGF; Yuan W; Salcedo R; Bahadiroglu E; Roy S; DeBlasio RN; Morrison RM; Chauvin JM; Ding Q; Zidi B; Lowin A; Chakka S; Gao W; Pagliano O; Ernst SJ; Rose A; Newman NK; Morgun A; Zarour HM; Trinchieri G; Dzutsev AK
Nat Med; 2022 Mar; 28(3):545-556. PubMed ID: 35228752
[TBL] [Abstract][Full Text] [Related]
2. Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients.
Zhang C; Wang J; Sun Z; Cao Y; Mu Z; Ji X
Cancer Sci; 2021 Aug; 112(8):3005-3017. PubMed ID: 34028936
[TBL] [Abstract][Full Text] [Related]
3. The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC.
Jin Y; Dong H; Xia L; Yang Y; Zhu Y; Shen Y; Zheng H; Yao C; Wang Y; Lu S
J Thorac Oncol; 2019 Aug; 14(8):1378-1389. PubMed ID: 31026576
[TBL] [Abstract][Full Text] [Related]
4. Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome.
Simpson RC; Shanahan ER; Batten M; Reijers ILM; Read M; Silva IP; Versluis JM; Ribeiro R; Angelatos AS; Tan J; Adhikari C; Menzies AM; Saw RPM; Gonzalez M; Shannon KF; Spillane AJ; Velickovic R; Lazar AJ; Damania AV; Mishra AK; Chelvanambi M; Banerjee A; Ajami NJ; Wargo JA; Macia L; Holmes AJ; Wilmott JS; Blank CU; Scolyer RA; Long GV
Nat Med; 2022 Nov; 28(11):2344-2352. PubMed ID: 36138151
[TBL] [Abstract][Full Text] [Related]
5. Microbial Influences on Immune Checkpoint Inhibitor Response in Melanoma: The Interplay between Skin and Gut Microbiota.
Bouferraa Y; Fares C; Bou Zerdan M; Boyce Kennedy L
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298653
[TBL] [Abstract][Full Text] [Related]
6. Dysbiosis of skin microbiome and gut microbiome in melanoma progression.
Mekadim C; Skalnikova HK; Cizkova J; Cizkova V; Palanova A; Horak V; Mrazek J
BMC Microbiol; 2022 Feb; 22(1):63. PubMed ID: 35216552
[TBL] [Abstract][Full Text] [Related]
7. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
8. Composition of the Gut Microbiota Associated with the Response to Immunotherapy in Advanced Cancer Patients: A Chinese Real-World Pilot Study.
Cheng X; Wang J; Gong L; Dong Y; Shou J; Pan H; Yu Z; Fang Y
J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36143126
[TBL] [Abstract][Full Text] [Related]
9. Functional dynamics of bacterial species in the mouse gut microbiome revealed by metagenomic and metatranscriptomic analyses.
Chung YW; Gwak HJ; Moon S; Rho M; Ryu JH
PLoS One; 2020; 15(1):e0227886. PubMed ID: 31978162
[TBL] [Abstract][Full Text] [Related]
10. The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer.
Peng Z; Cheng S; Kou Y; Wang Z; Jin R; Hu H; Zhang X; Gong JF; Li J; Lu M; Wang X; Zhou J; Lu Z; Zhang Q; Tzeng DTW; Bi D; Tan Y; Shen L
Cancer Immunol Res; 2020 Oct; 8(10):1251-1261. PubMed ID: 32855157
[TBL] [Abstract][Full Text] [Related]
11. A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition.
Pietrzak B; Tomela K; Olejnik-Schmidt A; Galus Ł; Mackiewicz J; Kaczmarek M; Mackiewicz A; Schmidt M
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358789
[TBL] [Abstract][Full Text] [Related]
12. Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy.
Dora D; Bokhari SMZ; Aloss K; Takacs P; Desnoix JZ; Szklenárik G; Hurley PD; Lohinai Z
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769093
[TBL] [Abstract][Full Text] [Related]
13. Roles of intestinal microbiota in response to cancer immunotherapy.
Cong J; Zhang X
Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2235-2240. PubMed ID: 30209679
[TBL] [Abstract][Full Text] [Related]
14. [Intestinal microbiome as a predictor of the anti-PD-1 therapy success: metagenomic data analysis].
Fedorov DE; Olekhnovich EI; Pavlenko AV; Klimina KM; Pokataev IA; Manolov AI; Konanov DN; Veselovsky VA; Ilina EN
Biomed Khim; 2020 Nov; 66(6):502-507. PubMed ID: 33372909
[TBL] [Abstract][Full Text] [Related]
15. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.
Baruch EN; Youngster I; Ben-Betzalel G; Ortenberg R; Lahat A; Katz L; Adler K; Dick-Necula D; Raskin S; Bloch N; Rotin D; Anafi L; Avivi C; Melnichenko J; Steinberg-Silman Y; Mamtani R; Harati H; Asher N; Shapira-Frommer R; Brosh-Nissimov T; Eshet Y; Ben-Simon S; Ziv O; Khan MAW; Amit M; Ajami NJ; Barshack I; Schachter J; Wargo JA; Koren O; Markel G; Boursi B
Science; 2021 Feb; 371(6529):602-609. PubMed ID: 33303685
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
Front Immunol; 2020; 11():612202. PubMed ID: 33488618
[TBL] [Abstract][Full Text] [Related]
17. Predicting cancer immunotherapy response from gut microbiomes using machine learning models.
Liang H; Jo JH; Zhang Z; MacGibeny MA; Han J; Proctor DM; Taylor ME; Che Y; Juneau P; Apolo AB; McCulloch JA; Davar D; Zarour HM; Dzutsev AK; Brownell I; Trinchieri G; Gulley JL; Kong HH
Oncotarget; 2022; 13():876-889. PubMed ID: 35875611
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
[TBL] [Abstract][Full Text] [Related]
19. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.
Davar D; Dzutsev AK; McCulloch JA; Rodrigues RR; Chauvin JM; Morrison RM; Deblasio RN; Menna C; Ding Q; Pagliano O; Zidi B; Zhang S; Badger JH; Vetizou M; Cole AM; Fernandes MR; Prescott S; Costa RGF; Balaji AK; Morgun A; Vujkovic-Cvijin I; Wang H; Borhani AA; Schwartz MB; Dubner HM; Ernst SJ; Rose A; Najjar YG; Belkaid Y; Kirkwood JM; Trinchieri G; Zarour HM
Science; 2021 Feb; 371(6529):595-602. PubMed ID: 33542131
[TBL] [Abstract][Full Text] [Related]
20. Altered Actinobacteria and Firmicutes Phylum Associated Epitopes in Patients With Parkinson's Disease.
Li Z; Lu G; Li Z; Wu B; Luo E; Qiu X; Guo J; Xia Z; Zheng C; Su Q; Zeng Y; Chan WY; Su X; Cai Q; Xu Y; Chen Y; Wang M; Poon WS; Luo X
Front Immunol; 2021; 12():632482. PubMed ID: 34276644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
